Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

IDEXX Laboratories, Inc. (IDXX) had Revenue of $3.90B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$3.90B
Net Income	$887.87M
Cost of Goods Sold	$1.52B
Gross Profit	$2.38B
Operating Expenses	$2.77B
Operating Income	$1.13B
Non-Operating Income/Expense	$-18.51M
Pre-Tax Income	$1.11B
Normalized Pre-Tax Income	$1.11B
Income after Taxes	$887.87M
Income from Continuous Operations	$887.87M
Consolidated Net Income/Loss	$887.87M
Normalized Income after Taxes	$887.87M
EBIT	$1.13B
EBITDA	$1.26B
Weighted-Average Shares Outstanding (Basic)	82.47M
Weighted-Average Shares Outstanding (Diluted)	83.25M
Earnings per Share (EPS) (Basic)	$10.77
Earnings per Share (EPS) (Diluted)	$10.67
Balance Sheet Financials
Current Assets	$1.40B
Property, Plant, and Equipment	$713.12M
Long-Term Assets	$1.89B
Total Assets	$3.29B
Current Liabilities	$1.07B
Long-Term Debt	$449.79M
Long-Term Liabilities	$630.21M
Total Liabilities	$1.70B
Common Equity	$1.60B
Tangible Shareholders Equity	$1.08B
Shareholders Equity	$1.60B
Common Shares Outstanding	81.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$929.00M
Cash Flow from Investing Activities	$-207.06M
Cash Flow from Financial Activities	$-878.07M
Beginning Cash	$453.93M
End Cash	$288.27M
Increase/Decrease in Cash	$-165.67M
Stock-Based Compensation	$60.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.31
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.22
Debt to Equity Ratio	0.54
Gross Margin	61.04%
Operating Margin	28.95%
EBIT Margin	28.95%
EBITDA Margin	32.28%
Pre-Tax Profit Margin	28.48%
Profit Margin	22.78%
Free Cash Flow	$808.08M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.18
Inventory Turnover	3.98
Receiveable Turnover	8.23
Days Sales in Receivables	44.35
Return on Equity	55.65%
Return on Tangible Equity	82.32%
Return on Assets	26.96%
Return on Investments	43.41%
Book Value Per Share	$19.55
Free Cash Flow per Share	$9.71
Operating Cash Flow per Share	$11.16

Data from Zacks Investment Research, Inc.